Description

Methyl 1,3-Dimethyl-5-(Isoxazol-5-Yl)Pyrazole-4-Carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its fused heterocyclic structure. This compound is of significant value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. It is primarily sought by research institutions and manufacturers in the pharmaceutical and agrochemical industries for developing next-generation compounds.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of complex drug candidates, especially those targeting central nervous system (CNS) disorders or possessing anti-inflammatory properties.
• Agrochemical Research: Serves as a core scaffold for developing new pesticides and herbicides with specific modes of action.
• Chemical Synthesis Building Block: Used in organic synthesis for constructing more complex nitrogen-containing heterocycles due to its reactive ester and pyrazole functionalities.
• Material Science Research: Potential monomer or additive in the research of specialty polymers and advanced functional materials.
• Contract Research & Development (CRO/CMO): Supplied to organizations engaged in custom synthesis and process development for client projects.

Basic Information

Product Name	Methyl 1,3-Dimethyl-5-(Isoxazol-5-Yl)Pyrazole-4-Carboxylate
CAS No.	175277-14-2
Molecular Formula	C10H11N3O3
Molecular Weight	221.21 g/mol
Synonyms	5-(Isoxazol-5-yl)-1,3-dimethyl-1H-pyrazole-4-carboxylic acid methyl ester; Methyl 5-(isoxazol-5-yl)-1,3-dimethyl-1H-pyrazole-4-carboxylate; 1,3-Dimethyl-5-(5-isoxazolyl)-1H-pyrazole-4-carboxylic acid methyl ester; 1H-Pyrazole-4-carboxylic acid, 5-(5-isoxazolyl)-1,3-dimethyl-, methyl ester; 175277-14-2; Pyrazole-isoxazole carboxylate derivative
EINECS	Contact for details

Quality Control

Our production of Methyl 1,3-Dimethyl-5-(Isoxazol-5-Yl)Pyrazole-4-Carboxylate adheres to stringent quality management protocols. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide a detailed Certificate of Analysis (COA) with each shipment, confirming compliance with agreed specifications. Our quality systems are designed to support cGMP and ISO standards for pharmaceutical intermediate manufacturing.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any individual impurity ≤ 0.5% Total impurities ≤ 1.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.